Literature DB >> 1518482

Clinically relevant optimization of 3-D conformal treatments.

R Mohan1, G S Mageras, B Baldwin, L J Brewster, G J Kutcher, S Leibel, C M Burman, C C Ling, Z Fuks.   

Abstract

In this paper a method of computer-aided optimization of 3-D conformal treatment plans is presented which incorporates models to predict the clinical consequences of resulting dose distributions. Even though these models are simplistic, it is submitted that their intelligent use leads to treatment plans which indicate lower normal tissue complications and higher tumor control. Dose distribution data, biological models, and observed normal tissue and tumor response data are used to compute tumor control and normal tissue complication probabilities for each of the critical normal structures encountered in a treatment plan. These quantities are combined into a single score using an objective function which incorporates the importance of each end point as assessed by the physician. Using the "simulated annealing" method of optimization, the beam weights are adjusted to maximize the score. Additional constraints are applied to ensure consistency of the results of optimization with the judgment of the physician. These optimization methods have been applied to conformal treatment plans consisting of multiple fixed fields with conformal field shaping. The results indicate that the methods presented have considerable potential.

Entities:  

Mesh:

Year:  1992        PMID: 1518482     DOI: 10.1118/1.596781

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  32 in total

1.  [Inverse radiotherapy planning].

Authors:  W Schlegel; P Kneschaurek
Journal:  Strahlenther Onkol       Date:  1999-05       Impact factor: 3.621

2.  Use of normal tissue complication probability models in the clinic.

Authors:  Lawrence B Marks; Ellen D Yorke; Andrew Jackson; Randall K Ten Haken; Louis S Constine; Avraham Eisbruch; Søren M Bentzen; Jiho Nam; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

3.  Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.

Authors:  Matthias Söhn; Di Yan; Jian Liang; Elisa Meldolesi; Carlos Vargas; Markus Alber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-26       Impact factor: 7.038

Review 4.  Linear quadratic and tumour control probability modelling in external beam radiotherapy.

Authors:  S F C O'Rourke; H McAneney; T Hillen
Journal:  J Math Biol       Date:  2008-09-30       Impact factor: 2.259

5.  Correlation between pneumonitis risk in radiation oncology and lung density measured with X-ray computed tomography.

Authors:  Abdulhamid Chaikh; Jacques Balosso
Journal:  Quant Imaging Med Surg       Date:  2016-08

6.  A framework for implementation of organ effect models in TOPAS with benchmarks extended to proton therapy.

Authors:  J Ramos-Méndez; J Perl; J Schümann; J Shin; H Paganetti; B Faddegon
Journal:  Phys Med Biol       Date:  2015-06-10       Impact factor: 3.609

7.  Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman model.

Authors:  Susan L Tucker; Lei Dong; Walter R Bosch; Jeff Michalski; Kathryn Winter; Radhe Mohan; James A Purdy; Deborah Kuban; Andrew K Lee; M Rex Cheung; Howard D Thames; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-02       Impact factor: 7.038

8.  Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer.

Authors:  M Rex Cheung; Susan L Tucker; Lei Dong; Renaud de Crevoisier; Andrew K Lee; Steven Frank; Rajat J Kudchadker; Howard Thames; Radhe Mohan; Deborah Kuban
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-22       Impact factor: 7.038

9.  Performance evaluation of an algorithm for fast optimization of beam weights in anatomy-based intensity modulated radiotherapy.

Authors:  Vaitheeswaran Ranganathan; V K Sathiya Narayanan; Janhavi R Bhangle; Kamlesh K Gupta; Sumit Basu; Vikram Maiya; Jolly Joseph; Amit Nirhali
Journal:  J Med Phys       Date:  2010-04

10.  Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons.

Authors:  Radhe Mohan; Amy Y Liu; Paul D Brown; Anita Mahajan; Jeffrey Dinh; Caroline Chung; Sarah McAvoy; Mary Frances McAleer; Steven H Lin; Jing Li; Amol J Ghia; Cong Zhu; Erik P Sulman; John F de Groot; Amy B Heimberger; Susan L McGovern; Clemens Grassberger; Helen Shih; Susannah Ellsworth; David R Grosshans
Journal:  Neuro Oncol       Date:  2021-02-25       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.